Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has successfu...
Elsevier, a global leader in advanced information and decision support, launches ScienceDirect AI, a cutting-edge g...
US-based Nosis Biosciences, an AI-driven biotechnology company specialising in RNA therapeutics for challenging cell typ...
A new ‘nanoball’ vaccine platform developed by experts in Japan will be tested as part of new research, supp...
Italy-based Tethis S.p.A., a pioneer in standardised liquid biopsy platform development, and Sheba Medical Center, ...
Identifying therapeutic gene targets is essential for advancing personalised medicine and addressing the genetic basis o...
Docquity, a leading healthtech company in Southeast Asia, and Rumah Sakit Umum Daerah (RSUD) Umar Wirahadikusumah Sumeda...
Taiwan-based Health2Sync, a leading digital health company specialising in chronic disease management, has raised over $...
India-based Augnito, a global leader in medical voice artificial intelligence (AI) technology, and Almoosa Health, a pre...
Royal Philips, a global leader in health technology, and SingHealth, Singapore's largest public healthcare clu...
Emirates Health Services (EHS) and Dell Technologies have signed a Memorandum of Understanding (MoU) to drive advancemen...
A research team led by Professor Kevin Tsia, programme director of the Biomedical Engineering Programme under the Facult...
NEOM, the sustainable region taking shape in northwest Saudi Arabia, has announced a strategic investment in US-based Pa...
Gene Solutions (GS), a pioneer genomic testing company in South-East Asia, aims to introduce a smart blood test to ...
Hikma Pharmaceuticals PLC, a British pharmaceutical group, has signed a strategic memorandum of understanding (MoU) with...
Nanyang Technological University, Singapore (NTU Singapore) spin-off company Gray Matter Solutions is partnering w...
The Ministry of Science and ICT and the Korea Research Institute of Bioscience and Biotechnology have announced the "Top...
Could you please share some details of the company's investment plans, and new product development in the coming years?&...
